Coronavirus 2019 and Cancer
People with cancer, cancer survivors, and those with compromised immune systems and other chronic medical conditions may be at a higher risk for the more severe form of COVID-19.
We want to share with you some resources to inform patients and support oncology professionals during the COVID-19 pandemic.
Websites and Online Resources
- World Global Cancer Coalitions/Alliances Covid-19 Statement, ABC Global Alliance, Global Lung Cancer Coalition, Global Colon Cancer Association, International Brain Tumour Alliance, International Kidney Cancer Coalition, Lymphoma Coalition, World Bladder Cancer Patient Coalition, World Ovarian Cancer Coalition (6 July 2020)
- Oncology nurses at the forefront to empower cancer patients during the pandemic, ESMO (4 May 2020)
- COVID-19 and Cancer, AACR Virtual meeting (28 April 2020)
- Navigating cancer in the age of COVID-19, Novartis Oncology interview to Dr Cardoso (24 April 2020)
- First report on the prognosis of COVID-19 patients with cancer in the US, ESMO (23 April 2020)
- Global Advocacy and Communications Effort Launched to Drive Action Against COVID-19 and Stop Future Pandemics, PRNewswire (22 April 2020)
- Impact of COVID-19 on breast cancer patients, Transforming Breast Cancer Together (20 April 2020)
- ESMO management and treatment adapted recommendations in the COVID-19 era: breast cancer, ESMO
- Coronavirus 2019: What People With Cancer Need to Know, Cancer.net (reviewed daily)
- Coronavirus (COVID-19) information, Breast Cancer Network Australia (reviewed daily)
- Frequently asked questions about coronavirus (COVID-19), Breast Cancer Network Australia (reviewed daily)
- ESP Knowledge Focus on SARS-CoV-2 and COVID-19, ESP (11 April 2020)
- OP-ED: Is there a silver lining for breast cancer patients?, Breast Cancer Network Australia (9 April 2020)
- Cancer care during the COVID-19 pandemic: an ESMO guide for patients, ESMO (8 April 2020)
- Breast cancer treatment during the coronavirus outbreaks, Living Beyond Breast Cancer (1 April 2020)
- Splitting healthcare teams may help to reduce disruption in patient care, ESMO (26 March 2020)
- Common Questions About Coronavirus 2019 and Cancer: Answers for Patients and Survivors, Cancer.net (20 March 2020)
- Coronavirus, COVID-19, and Cancer, American Cancer Society
- Coronavirus, COVID-19 and cancer, ESMO
- COVID-19 Patient Care Information, American Society of Clinical Oncology
- Coronavirus Guide for Cancer Patients, SurvivorNet
- Advice on Coronavirus for people with cancer, Breast Cancer Now
- Cancer and coronavirus (COVID-19), Macmillan Cancer Support
- Information for people with cancer about COVID-19, Cancer Australia
- CORONAVIRUS (COVID-19), Susan G. Komen
- Coronavirus: what cancer patients need to know, Fred Hutch (6 March 2020)
- How to Manage Cancer Care during COVID-19 Pandemic, National Comprehensive Cancer Network
- Coronavirus: Steps to Take for People With Breast Cancer, Living Beyond Breast Cancer (19 March 2020)
- Coronavirus (COVID-19), National Institute for Health and Care Excellence - NICE
- Coronavirus and the palliative care response, European Association for Palliative Care
- The MBC community and COVID-19, mBC Alliance
Literature
- Various resources available to support research, higher education and health communities, Elsevier (reviewed periodically)
- Novel Coronavirus Information Center, Elsevier (reviewed periodically)
- Various resources available to support research, higher education and health communities, Elsevier (reviewed periodically)
- Rethinking cancer clinical trials for COVID-19 and beyond, Nature Cancer (29 May 2020)
- Cancer and COVID-19: what do we really know?, The Lancet (29 May 2020) Poor clinical outcomes for patients with cancer during the COVID-19 pandemic, The Lancet (29 May 2020)
- Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study, The Lancet (29 May 2020)
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study, The Lancet (28 May 2020)
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study, The Lancet (28 May 2020)
- Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic, The Lancet (13 May 2020)
- How can I break bad news remotely?, BMJ (12 May 2020)
- Safeguarding cancer care in a post-COVID-19 world, The Lancet (1 May 2020)
- Preparedness for COVID-19 in the oncology community in Africa, The Lancet (1 May 2020)
- Managing COVID-19 in the oncology clinic and avoiding the distraction effect, Annals of Oncology (May 2020)
- ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer, ESMO Open (26 April 2020)
- COVID-19 and its ramifications for cancer patients in low-resource settings: Ghana as a case study, eCancer (20 April 2020)
- Recommendations for Triage, Prioritization and Treatment of Breast Cancer Patients During the COVID-19 Pandemic, The Breast (16 April 2020)
- Oncology Practice During the COVID-19 Pandemic, Jama (13 April 2020)
- Caring for patients with cancer in the COVID-19 era, Nature Medicine (16 April 2020)
- Advice on the use of masks in the context of COVID-19, World Health Organization (6 April 2020)
- COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis, JCO Global Oncology (6 April 2020)
- GCancer guidelines during the COVID-19 pandemic, The Lancet (2 April 2020)
- Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic (27 March 2020)
- The official French guidelines to protect patients with cancer against SARS-CoV-2 infection, The Lancet (25 March 2020)
- SARS-CoV-2 transmission in Patients with cancer at a tertiary care hospital in Wuhan, China, JAMA Oncology (25 March 2020)
- Recommendations for Prioritization, treatment and triage of breast cancer patients during the COVID-19 Pandemic, The American Society of Breast Surgeons (24 March 2020)
- Literature review of accepted relevant papers, REACTing (19 March 2020)
- FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic, FDA (18 March 2020)
- Risk of COVID-19 for patients with cancer, The Lancet (3 March 2020)
- FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic, FDA (March 2020)
E-learning and videos
- COVID-19 and Breast Cancer: Ask the Experts, ABC Global Alliance (8 June 2020)
- Breast cancer in the era of COVID-19, ESMO (14 May 2020)
- States are reopening...now what?, Susan G Komen (14 May 2020)
- COVID-19 experiences in African institutions, ChartRounds (6 May 2020)
- COVID-19 and Cancer in Victoria: Models of Care, Victorian Comprehensive Cancer Centre(20 April 2020)
- Living with mets in the time of COVID-19, Living Beyond Breast Cancer (18 April 2020)
- COVID 19 – Oncological risks and guidelines, European School of Oncology (8 April 2020)
- Guidelines and pathways of breast cancer care during the COVID-19 pandemic, European School of Oncology (7 April 2020)
- Telemedicine, the coronavirus, and breast cancer, Living Beyond Breast Cancer (6 April 2020)
- COVID-19 and radiation oncology: any clinical and organisational impact?, European School of Oncology (31 March 2020)
- COVID-19 and breast cancer, Breast Cancer Foundation NZ (30 March 2020)
- COVID-19 Outbreak: Breast Cancer Coronavirus Questions Answered, Patient Power (27 March 2020)
- OncoAlert Round Table Discussions: The Global COVID19 Experience, European School of Oncology (26 March 2020)
- COVID-19: Describing a new disease (Meyerowitz & Richterman), MGH Division of Infectious Diseases (25 March 2020)
- Cancer care during COVID-19 in Italy: a young oncologist's perspective, ESMO open cancer horizons - Podcast (25 March 2020)
- The impact of coronavirus on oncological care, European School of Oncology (18 March 2020)
- OncoAlert Round Table The Italian COVID19 Experience, European School of Oncology (17 March 2020)
Resources in other languages
- Brustkrebs Deutschland e.V. , DE
- COVID-19 and breast cancer population: French guidelines for clinical practice, Nice-St Paul de Vence, FR
- Emergenza COVID-19 indicazioni GIPAM relative alla gestione dei campioni citologici e istologici di patologia mammaria, SIAPEC-IAP, IT
Answers to questions about COVID-19 published herein are provided for voluntary, informational use in the rapidly evolving novel coronavirus crisis. This information does not constitute medical or legal advice, is not intended for use in the diagnosis or treatment of individual conditions, does not endorse products or therapies, recommend or mandate any particular course of medical care, and is not a statement of the standard of care. New evidence may emerge between the time information is developed and when it is published or read. The information is not comprehensive or continually updated. This information is not intended to substitute for the independent professional judgment of the treating provider in the context of treating the individual patient. The ABC Global Alliance provides this information on an “as is” basis, and makes no warranty, express or implied, regarding the information. The ABC Global Alliance specifically disclaims any warranties of merchantability or fitness for a particular use or purpose. The ABC Global Alliance assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of this information or for any errors or omissions.